Lake Street Private Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Hold
1,165
0.03% 252
2026
Q1
$228K Sell
1,165
-3
-0.3% -$583 0.03% 238
2025
Q4
$203K Buy
1,168
+3
+0.3% +$546 0.02% 271
2025
Q3
$222K Buy
+1,165
New +$207K 0.03% 253
2023
Q2
Sell
-16,001
Closed -$15.8K 293
2023
Q1
$15.8K Buy
16,001
+14,576
+1,023% +$2.09M ﹤0.01% 282
2022
Q4
$223K Buy
+1,425
New +$205K 0.05% 252
2022
Q2
Sell
-1,525
Closed -$209K 307
2022
Q1
$209K Hold
1,525
0.04% 296
2021
Q4
$264K Sell
1,525
-168
-10% -$25.6K 0.05% 275
2021
Q3
$246K Buy
1,693
+143
+9% +$20.9K 0.06% 198
2021
Q2
$206K Sell
1,550
-25
-2% -$3.27K 0.05% 205
2021
Q1
$202K Sell
1,575
-380
-19% -$46.8K 0.06% 199
2020
Q4
$233K Sell
1,955
-85
-4% -$10.4K 0.07% 179
2020
Q3
$234K Sell
2,040
-105
-5% -$12.4K 0.08% 152
2020
Q2
$244K Sell
2,145
-3,470
-62% -$368K 0.09% 142
2020
Q1
$451K Buy
+5,615
New +$581K 0.21% 96

Other funds holding DGX

Lake Street Private Wealth's DGX Position: Q2 2026 in Review

Lake Street Private Wealth held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,165 shares worth $247K. The position accounts for 0.03% of the portfolio, ranked #252.

Lake Street Private Wealth first reported a position in DGX in Q1 2020 and has held it in 15 quarters since. The position peaked at $451K in Q1 2020. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Lake Street Private Wealth held 1,165 shares of Quest Diagnostics worth $247K as of Q2 2026.
  • Lake Street Private Wealth left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.03% of Lake Street Private Wealth's portfolio in Q2 2026, its #252 holding.
  • Lake Street Private Wealth first reported a position in Quest Diagnostics in Q1 2020 and has held it in 15 quarters since.
  • Lake Street Private Wealth's Quest Diagnostics position peaked at $451K in Q1 2020.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Lake Street Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.